+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07335627

Study of Clindamycin Treatment for Streptococcus Joint Infections After Joint Replacement Surgery

Led by University Hospital, Strasbourg, France · Updated on 2026-01-13

260

Participants Needed

1

Research Sites

2 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the success of clindamycin compared to other antibiotics in treating periprosthetic joint infections caused by Streptococcus species. Clindamycin is studied because it has high oral availability and penetrates bone and joint tissues well, making it a recommended option for certain osteoarticular infections in France. The study aims to determine if clindamycin is at least as effective as commonly used treatments for these infections. The study observes adult patients who have had surgery for periprosthetic Streptococcus infections and compares the outcomes of those treated with clindamycin to those receiving other antibiotics. It collects data from patients operated on between 2013 and 2024 in associated centers. There is no intervention assigned, as this is an observational study assessing real-world antibiotic use. Participants will be monitored for treatment success, with the main measure being the therapeutic success of the combined medical and surgical approach one year after completing antibiotic treatment. The total period of observation extends through surgery and up to at least one year post-treatment to evaluate outcomes. Safety and treatment adherence are tracked through routine medical follow-up.

CONDITIONS

Brief Title

Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection

Research Team

S

Stéphane KLEIN, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here